Medicare Enrolled

Dr. Jaime Goodman, M.D.

Endocrinology · Mount Vernon, OH
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Speaking/Promotional
1330 COSHOCTON AVE, Mount Vernon, OH 43050
7403939000
In practice since 2008 (18 years)
NPI: 1790949006 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Goodman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goodman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goodman

Dr. Jaime Goodman is an endocrinology specialist in Mount Vernon, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Goodman performed 211 Medicare services across 161 unique beneficiaries.

Between the years covered by Open Payments, Dr. Goodman received a total of $88,936 from 43 pharmaceutical and/or device companies across 1179 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goodman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 211 Medicare services $88,936 industry payments

Medicare Practice Summary

Medicare Utilization ↗
211
Medicare services
Bottom 22% in OH for endocrinology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
161
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~12 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
101 $26 $90
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
33 $92 $195
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
24 $104 $169
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $61 $194
Continuous glucose monitoring, tissue fluid
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin.
18 $45 $245
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
14 $55 $78
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$88,936
Total received (2018-2024)
Avg $12,705/year across 7 years
Top 8% in OH for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
1,179
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$71,504 (80.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,274 (17.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,159 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,679
2023
$2,111
2022
$2,367
2021
$3,167
2020
$9,854
2019
$29,937
2018
$30,822

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$4,513
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,717
Novo Nordisk Inc
$470
Corcept Therapeutics
$328
Abbott Laboratories
$299
Xeris Pharmaceuticals, Inc.
$159
Novartis Pharmaceuticals Corporation
$142
Esperion Therapeutics, Inc.
$141
ABBVIE INC.
$141
Amgen Inc.
$139
IBSA Pharma Inc.
$94
Alexion Pharmaceuticals, Inc.
$91
SANOFI-AVENTIS U.S. LLC
$80
Insulet Corporation
$79
Avvisto Therapeutics, LLC
$68
Dexcom, Inc.
$63
Medtronic, Inc.
$63
Radius Health, Inc.
$35
Nevro Corp.
$24
Tandem Diabetes Care, Inc.
$17
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 81.5% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$63,794
Lilly USA, LLC
$6,485
Novo Nordisk Inc
$5,198
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,048
AstraZeneca Pharmaceuticals LP
$1,005
Amgen Inc.
$964
Abbott Laboratories
$702
Corcept Therapeutics
$681
Merck Sharp & Dohme Corporation
$618
IBSA Pharma Inc.
$484
Xeris Pharmaceuticals, Inc.
$440
Medtronic MiniMed, Inc.
$403
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$398
Novartis Pharmaceuticals Corporation
$359
MannKind Corporation
$344
Amarin Pharma Inc.
$261
Alexion Pharmaceuticals, Inc.
$251
ABBVIE INC.
$238
Bayer HealthCare Pharmaceuticals Inc.
$189
Mannkind Corporation
$183
Medtronic, Inc.
$176
Janssen Pharmaceuticals, Inc
$174
Radius Health, Inc.
$165
Insulet Corporation
$162
Kowa Pharmaceuticals America, Inc.
$147
Esperion Therapeutics, Inc.
$141
Nevro Corp.
$112
Aegerion Pharmaceuticals, Inc.
$110
Dexcom, Inc.
$106
AbbVie, Inc.
$100
Merck Sharp & Dohme LLC
$90
Shire North American Group Inc
$79
AbbVie Inc.
$75
Avvisto Therapeutics, LLC
$68
Tandem Diabetes Care, Inc.
$43
Regeneron Healthcare Solutions, Inc.
$26
Clarus Therapeutics Inc.
$25
Horizon Therapeutics plc
$22
Ultragenyx Pharmaceutical Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Endo Pharmaceuticals Inc.
$14
Zealand Pharma US, Inc.
$14
RECORDATI_RARE_DISEASES_INC.
$13
Top 3 companies account for 84.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Aimovig · BAQSIMI · CYCLOSET · Crysvita · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · Macrilen · Minimed 530G · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · Omnia · Omnipod · Ozempic · PRALUENT · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOTAGLIFLOZIN · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZEGALOGUE · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for endocrinology in OH.

Looking for an endocrinology specialist in Mount Vernon?
Compare endocrinologists in the Mount Vernon area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
3
Per 100K population
4.8
County median income
$73,988
Nearest hospital
KNOX COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Goodman is a remote monitoring specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of OH peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Goodman experienced with continuous glucose monitoring with interpretation?
Based on Medicare claims data, Dr. Goodman performed 101 continuous glucose monitoring with interpretation services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goodman receive payments from pharmaceutical companies?
Yes. Dr. Goodman received a total of $88,936 from 43 companies across 1,179 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goodman's costs compare to other endocrinologists in Mount Vernon?
Dr. Goodman's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goodman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →